跳至主要内容
临床试验/CTRI/2019/01/017039
CTRI/2019/01/017039已完成2 期

Assessment of the skin Irritancy of Different Formulations in Human using patch test on Sensitive Skin

Dabur India Ltd0 个研究点目标入组 26 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Voluntary men and /or women.
  • 2. Photo Type III and IV.
  • 3. Having Apparently healthy skin on test area (upper arms)
  • 4. Willingness to discontinue the use of cleansing and/or cosmetic products in the treatment areas during the course of the study
  • 5. For whom the investigator considers that the compliance will be correct.
  • 6. Cooperating, informed of the need and duration of the examinations [3 visits (more if necessary)] and ready to comply with protocol procedures.
  • 7. Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives.
  • 8.Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study.
  • 9. Willingness to avoid water contact (i.e.: swimming) or activity which causes excessive sweating (i.e.: exercise, saunaâ?¦), during the course of the study.
  • 10. Ready to wear loose cotton clothes.
  • 11. Should be able to read and write (in English, Hindi or Marathi).
  • 12. Having valid proof of identity and age proof.
  • 13. For Women only - A women who is NOT pregnant or NOT a nursing (Lactating) mother

排除标准

  • 1. People who have a job involving water contact or a job which causes perspiration. (Routine work can be done. No carrying out strenuous activities like excessive/brisk walking, exercising etc).
  • 2. Scars, excessive terminal hair or tattoo on the studied area or henna tattoo anywhere on the body.
  • 3. Dermatological infection/ pathology on the level of studied area.
  • 4. Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye).
  • 5. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures.
  • 6. Chronic illness which may influence the outcome of the study.
  • 7. Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
  • 8. Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.
  • 9. For Women only, A women who is pregnant or is a nursing (Lactating) mother
  • 10. For Women only, Positive results in UPT test

研究者

相似试验